Kimberly-Clark Corporation $KMB Stake Lessened by International Assets Investment Management LLC

International Assets Investment Management LLC lessened its position in shares of Kimberly-Clark Corporation (NASDAQ:KMB) by 54.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 12,847 shares of the company’s stock after selling 15,053 shares during the period. International Assets Investment Management LLC’s holdings in Kimberly-Clark were worth $1,252,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Lebenthal Global Advisors LLC lifted its stake in shares of Kimberly-Clark by 9.9% during the 3rd quarter. Lebenthal Global Advisors LLC now owns 10,023 shares of the company’s stock worth $977,000 after purchasing an additional 907 shares during the period. Partners Wealth Management LLC acquired a new stake in shares of Kimberly-Clark during the third quarter worth $215,000. Choreo LLC grew its position in shares of Kimberly-Clark by 22.2% in the third quarter. Choreo LLC now owns 10,887 shares of the company’s stock valued at $1,076,000 after purchasing an additional 1,976 shares during the period. Dynamic Financial Group grew its position in shares of Kimberly-Clark by 28.5% in the third quarter. Dynamic Financial Group now owns 2,428 shares of the company’s stock valued at $237,000 after purchasing an additional 538 shares during the period. Finally, Redmond Asset Management LLC purchased a new stake in shares of Kimberly-Clark in the third quarter valued at $1,352,000. Hedge funds and other institutional investors own 76.29% of the company’s stock.

Key Headlines Impacting Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: The completed Kenvue acquisition expands Kimberly-Clark’s presence in health and wellness and adds brands including Tylenol to its portfolio, potentially creating new growth opportunities. The deal’s enterprise value was reported at nearly $49 billion. Kimberly Clark Completes Kenvue Acquisition
• Positive Sentiment: Kimberly-Clark’s dividend history may appeal to income-focused investors: it has paid dividends for 92 consecutive years and increased payouts for 54 years. Its dividend yield was cited at about 4.7%, with recent annual net income of $2.5 billion in 2024 and $2 billion in 2025 supporting the payout. Is Kimberly-Clark the Safest Dividend Stock You Can Buy Now?
• Positive Sentiment: Reports that ETFs bought $132.9 million of KMB shares on Oct. 30 point to notable institutional demand, though the report alone does not establish whether that buying will continue. ETFs Bought $132.9 Million of Kimberly-Clark
• Neutral Sentiment: Investors are looking ahead to the Nov. 5 earnings report for updates on quarterly performance and the company’s outlook, including how management expects to handle the Kenvue combination. Kimberly-Clark Acquires Kenvue Ahead of Earnings
• Negative Sentiment: The nearly $49 billion transaction is large, and Kimberly-Clark’s exchange offer involved up to $7 billion of new company notes plus cash for Kenvue notes. The added financing burden and execution risks could weigh on investors’ assessment of the deal’s benefits. Exchange Offers for Kenvue Notes

Kimberly-Clark Trading Up 4.1%

NASDAQ:KMB opened at $108.79 on Thursday. The company has a quick ratio of 0.69, a current ratio of 0.91 and a debt-to-equity ratio of 3.45. Kimberly-Clark Corporation has a 1-year low of $92.42 and a 1-year high of $116.82. The firm has a market capitalization of $36.18 billion, a price-to-earnings ratio of 14.02, a price-to-earnings-growth ratio of 6.03 and a beta of 0.25. The stock has a fifty day simple moving average of $102.61 and a 200 day simple moving average of $103.14.

Kimberly-Clark (NASDAQ:KMB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.01 by ($0.21). Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%. The company had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.22 billion. During the same quarter in the previous year, the firm posted $1.92 EPS. Kimberly-Clark’s quarterly revenue was up .6% on a year-over-year basis. Sell-side analysts forecast that Kimberly-Clark Corporation will post 6.83 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on KMB. TD Cowen lowered their target price on Kimberly-Clark from $104.00 to $97.00 and set a “hold” rating for the company in a research note on Tuesday, October 13th. Zacks Research cut Kimberly-Clark from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 20th. DA Davidson increased their price target on Kimberly-Clark from $106.00 to $116.00 and gave the company a “neutral” rating in a report on Wednesday, August 5th. BNP Paribas Exane raised their price objective on Kimberly-Clark from $101.00 to $110.00 and gave the company a “neutral” rating in a research note on Friday, October 16th. Finally, Canaccord Genuity Group assumed coverage on Kimberly-Clark in a report on Friday, October 23rd. They set a “hold” rating and a $105.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $110.67.

Kimberly-Clark Profile

Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.